The authors regret that there are 2 errors in the published article:
- 1)in table 1 data from MS and control group respectively have been switched on the 3 parameters: 25FWT, 9-HPT and LVCA;
- 2)in table 2 one line concerning follow-up is placed in the wrong column for all 3 tests.
The authors would like to apologise for any inconvenience caused.
Article info
Publication history
Published online: January 15, 2020
Identification
Copyright
© 2020 Elsevier B.V. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MSMultiple Sclerosis and Related DisordersVol. 37
- PreviewMultiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system (Thompson, 2018). In Denmark the prevalence of MS is among the highest in the world with approximately 300 per 100.000 citizens being affected (Koch-Henriksen et al., 2018). MS is associated with a range of physical, psy-chiatric and cognitive symptoms. A large proportion of people with MS (pwMS) (40–75%) have cognitive im-pairment, primarily reduced information processing speed, memory and executive functions, and these symptoms may appear already in the early course of the disease (Trenova et al., 2016; Filippi et al., 2018).
- Full-Text
- Preview
